Breast Cancer

We build your team of breast cancer experts based on your needs, providing personalized, compassionate care.

First, we identify the specific type of breast cancer using microscopic analysis, genetic testing, and imaging. Then, we create an individualized treatment plan for you. At the Breast Cancer Center, part of NYU Langone’s Perlmutter Cancer Center, our experts provide the most advanced treatments, such as breast-conserving surgery and targeted drugs, and our researchers evaluate promising new treatments for breast cancer in clinical trials.

We offer comprehensive support services including fertility preservation counseling, psychological support, and integrative therapies.

We counsel women who are at high risk for developing breast cancer, and our experts frequently provide second opinions.

Clinical Trials and Research Studies

Phase 2

A randomized phase II trial of adjuvant trastuzumab emtansine (T-DM1) followed by subcutaneous trastuzumab versus paclitaxel in combination with subcutaneous trastuzumab for Stage I HER2-positive breast cancer (ATEMPT 2.0)

Learn More

Phase 3

eMonarcHER: A Randomized Double Blind Placebo-Controlled Phase 3 Study of Abemaciclib plus Standard Adjuvant Endocrine Therapy in Participants with High-Risk Node-Positive HR+ HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy

Learn More

Phase 3

The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD) A Double-Blinded Phase III Randomized Trial of T-DM1 Compared with T-DM1 and Tucatinib

Learn More

Phase 1

An Open-label Multicenter Dose Escalation Phase 1b Study to Assess the Safety and Pharmacokinetics of Subcutaneous Delivery of Amivantamab a Human Bispecific EGFR and cMet Antibody for the Treatment of Subjects with Advanced Non-Small Cell Lung Cancer

Learn More